Tuesday, 02 January 2024 12:17 GMT

Cap-Free, Hidden-Needle Onestep Lancing Pen Debuts In Spain--First Step Of Sterilance's European Roll-Out


(MENAFN- PR Newswire) Onestep is the world's first cap-free, four-step lancing pen that keeps the needle hidden from start to finish and drives it with patent-protected Total Path ControlTM (TPC) vertical-drive technology , delivering virtually painless sampling while halving preparatory motions. The devices are now available in Spain through select pharmacy outlets and partner e-commerce stores, with wider European roll-out to follow.

What makes Onestep different

  • Single-step needle loading & removal - insert a SoftSense lancet and simply twist off its protective cap; no pen-cap removal is ever required.
  • Four-step workflow - insert, twist, press, eject - around 70 % fewer actions than conventional pens.
  • TPCTM vertical drive guides the needle in a straight path, reducing vibration and tissue trauma for an almost painless finger-stick.
  • Needle concealed throughout , easing needle anxiety and lowering accidental-injury risk.

In a recent evaluation with 30 frequent testers, 92 % reported "little or no pain," while 87 % felt safer because they never saw the needle.

Market context

Spain is home to an estimated 5.1 million adults with diabetes , one of the highest prevalence rates in Europe. Low-pain, easy-to-use devices such as Onestep can help improve adherence to daily self-monitoring, a cornerstone of effective diabetes management.

Availability

Onestep and SoftSense are now on sale in Spain via select brick-and-mortar pharmacies and partner e-commerce sites . Broader retail and pharmacy distribution across additional EU markets will commence in the coming months.

Compliance & resources

Onestep and SoftSense are CE-MDR and ISO 13485 certified and engineered for frequent, home-based capillary sampling.
For more information about Onestep and to explore its features, visit:
.
For media or distribution enquiries, please contact: [email protected] .

Photo -

MENAFN10072025003732001241ID1109782186



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search